Musclepharm Corporation Net Income per Employee (MSLP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Musclepharm Corporation  (MSLP)
 

Musclepharm Net Income per Employee

MSLP's Quarterly Results, Trends, Rankings, Statistics
Musclepharm Corporation recorded a cumulative net loss of $-19 million during 12 month ending in the first quarter 2022.
The Healthcare sector has seen employees of 102 other companies achieving higher income per employee. While Musclepharm's total ranking has deteriorated compared to the previous quarter from 1726 to 3217.


What is Income per Employee Ratio?






MSLP Net Income per Employee (Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -77,665 -51,879 -13,185 5,407 13,464
MSLP's Total Ranking # 3217 # 1726 # 1605 # 1329 # 1202
Seq. Net Income Change - - - - -96.67 %


MSLP Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 103
Healthcare Sector # 338
Overall Market # 3217

Net Income per Employee Statistics
High Average Low
$ 13,464 $ -60,008 $ -235,437
(Mar 31 2021)   (Sep. 30, 2015)







Companies with similar Income per Employee for 12 month ending Mar 31 2022, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2022Number of Employees Mar 31 2022


Date modified: 2026-08-29T17:19:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.